Why Should Pathologists Care about Participating in MIPS? - a podcast by CAP
from 2021-05-06T18:55:58
::
::
In this CAPcast, we’ll speak with Diane Cardona, MD, FCAP, Chair of the Quality and Clinical Data Registry Affairs Committee, about why eligible pathologists should consider MIPS participation as a strategy to help protect revenues as well as a strategy to demonstrate their value instead of seeking a COVID exemption.
Further episodes of CAPcast from the College of American Pathologists
Further podcasts by CAP
Website of CAP